BTIG Downgrades Liquidia to Neutral Following Patent Infringement Ruling

Key Facts

1BTIG downgraded Liquidia Corporation to Neutral following a US court ruling on patent infringement.

2The court ruling pertains to Liquidia infringing on patents held by United Therapeutics.

BTIG downgraded Liquidia Corporation to Neutral following a US court ruling. Investing.com reported that the court found Liquidia infringed on patents held by United Therapeutics, a legal setback that creates uncertainty regarding the company's product pipeline and commercialization rights.

LQDA closed at $30.26 on September 30, 2026, after reaching a session low of $29.86. The downgrade and the negative legal ruling on core intellectual property have placed downward pressure on the stock as investors assess the impact on the company's future operations.